Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.

about

Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections.

Item

http://www.wikidata.org/entity/Q36147444

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Genetic engineering of Francis ...... domonas aeruginosa infections.

@ast

Genetic engineering of Francis ...... domonas aeruginosa infections.

@en

type

Item

label

Genetic engineering of Francis ...... domonas aeruginosa infections.

@ast

Genetic engineering of Francis ...... domonas aeruginosa infections.

@en

prefLabel

Genetic engineering of Francis ...... domonas aeruginosa infections.

@ast

Genetic engineering of Francis ...... domonas aeruginosa infections.

@en

P1476

Genetic engineering of Francis ...... domonas aeruginosa infections.

@en

P2093

Brandon Chang

http://www.w3.org/2001/XMLSchema#string

Brian Phair

http://www.w3.org/2001/XMLSchema#string

Brianna N Kobe

http://www.w3.org/2001/XMLSchema#string

Chelsea Camerlengo

http://www.w3.org/2001/XMLSchema#string

Cory M Robinson

http://www.w3.org/2001/XMLSchema#string

Deanna M Schmitt

http://www.w3.org/2001/XMLSchema#string

Devin Sindeldecker

http://www.w3.org/2001/XMLSchema#string

Jialin Liao

http://www.w3.org/2001/XMLSchema#string

Joo-Yong Jung

http://www.w3.org/2001/XMLSchema#string

Joseph Horzempa

http://www.w3.org/2001/XMLSchema#string

P2860

Tularemia

Animal Protection and Structural Studies of a Consensus Sequence Vaccine Targeting the Receptor Binding Domain of the Type IV Pilus of Pseudomonas aeruginosa

Vaccines and immunotherapy against Pseudomonas aeruginosa

Pseudomonas aeruginosa porin OprF exists in two different conformations

A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model.

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.

Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation.

Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis.

P304

82-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21655979.2015.1011033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271329473

http://www.w3.org/2001/XMLSchema#string

P698

25617059

http://www.w3.org/2001/XMLSchema#string

P932

4601302

http://www.w3.org/2001/XMLSchema#string